This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Interactions

Authoring team

  • erythromycin may increase bromocriptine plasma levels
  • there have been reports of psychosis with concomitant bromocriptine and pseudoephedrine administration
  • the beneficial effects of dopamine agonists will be counteracted by the use of dopamine antagonists, including antipsychotic agents
  • concomitant levo dopa use with a dopamine agonist leads to an increased risk of dopamine-related side-effects

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.